Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 277 results found. Search for [ Biotechnology company ]

Results 1 to 21 of 277
BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


Aprajita Sharma
October 6, 2020
With the construction of MSCI India Domestic & World Healthcare 45 Index Fund for Edelweiss, the MSCI has forayed into the Indian market for the first time


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
September 23, 2020
Phase 1 clinical trial of Codagenix' intranasal, live-attenuated vaccine candidate for SARS-CoV-2, is expected to initiate in the United Kingdom by the end of 2020


BusinessToday.In
September 16, 2020
Stocks to watch today on September 16: Aurobindo Pharma, SpiceJet, Future Enterprises, Infosys, IRB Infrastructure among others are the top stocks to watch out for in Wednesday's trading session.


PB Jayakumar
September 11, 2020
\"It (candidate drug PNB-001) has shown remarkable results in lung inflammation and ARDS (Acute Respiratory Distress Syndrome)\", says PN Balaram, CEO of PNB Vesper


BusinessToday.In
September 1, 2020
COVID-19 vaccine: The University of Oxford and AstraZeneca PLC has developed the first vaccine candidate to start the final round of testing of the coronavirus vaccine


BusinessToday.In
August 29, 2020
COVID-19 vaccine update: The expert group of the committee, headed by Dr. VK Paul, is also in contact with domestic as well as multinational vaccine makers to understand how soon a COVID-19 vaccine will be ready


PB Jayakumar
August 14, 2020
The Western world and the big pharma are upset. They say Russia has not done adequate safety and efficacy studies and the claim is based on testing on less than 100 human volunteers


BusinessToday.In
August 11, 2020
COVID-19 vaccine: The committee has the responsibility of financing, buying, distribution and administration of the coronavirus vaccine


PTI
August 7, 2020
The company has successfully completed the Phase-I and Phase II studies. Phase-III clinical study is expected to be initiated by December 2020.


Reuters
August 5, 2020
The company said it could start a large pivotal Phase III trial as soon as late September, and on a conference call added that it could produce 1 billion to 2 billion doses of the vaccine in 2021


BusinessToday.In
August 4, 2020
Market cap of Wockhardt rose to Rs 3,695.50 crore as of today's session. The stock price of Wockhardt has gained 21% in one month and 42% since the beginning of the year


Reuters
August 4, 2020
The Phase III trial is expected to enroll up to 2,400 participants who live or work at facilities that have had a recently diagnosed case of COVID-19


Joe C Mathew
August 3, 2020
Indian vaccine manufacturers are waiting for a vaccination plan from the government so that they can set aside stocks of vaccines when they are approved for production


BusinessToday.In
July 31, 2020
The London-based maker of Lucky Strike cigarettes has claimed to have developed the inoculation using protein from tobacco leaves


Associated Press
July 31, 2020
EU foreign policy chief Josep Borrell said on Thursday the sanctions are a travel ban and asset freeze to natural persons and an asset freeze to entities or bodies


BusinessToday.In
July 28, 2020
Coronavirus vaccine news: Serum Institute of India CEO Adar Poonawalla had earlier stated that the company would reserve 50 per cent of the vaccine doses for use in India


BusinessToday.In
July 21, 2020
Vaccine major Serum Institute of India's CEO Adar Poonawalla said on Monday the company will apply for COVID-19 vaccine trials within a week and will soon begin manufacturing the vaccine, developed by Oxford University, in large volumes


PAGES 1 OF 14  12345